4//SEC Filing
Sucampo Pharmaceuticals, Inc. 4
Accession 0000899243-16-036406
CIK 0001365216operating
Filed
Dec 28, 7:00 PM ET
Accepted
Dec 29, 5:15 PM ET
Size
5.2 KB
Accession
0000899243-16-036406
Insider Transaction Report
Form 4
Ueno Ryuji
DirectorCEO, Chief Scientific Officer10% Owner
Transactions
- Gift
Class A Common Stock
2016-12-19−130,760→ 0 total(indirect: By Trust)
Holdings
- 9,006,585(indirect: By LLC)
Class A Common Stock
Documents
Issuer
Sucampo Pharmaceuticals, Inc.
CIK 0001365216
Entity typeoperating
Related Parties
1- filerCIK 0001365216
Filing Metadata
- Form type
- 4
- Filed
- Dec 28, 7:00 PM ET
- Accepted
- Dec 29, 5:15 PM ET
- Size
- 5.2 KB